Practical guidelines for the treatment of malignant gliomas

Western Journal of Medicine

Volumn 168, Issue 2, 1998, Pages 114-120

  Chamberlain, Marc C ^a,c   Kormanik, Patty A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; FLUOROURACIL; HYDROXYUREA; LOMUSTINE; MITOLACTOL; NITROSOUREA DERIVATIVE; PROCARBAZINE; RADIOSENSITIZING AGENT; TIOGUANINE; VINCRISTINE;

CANCER ADJUVANT THERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; GLIOBLASTOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; RADIATION DOSE; RADIOSURGERY; REVIEW;

ALGORITHMS; BRAIN NEOPLASMS; CLINICAL PROTOCOLS; COMBINED MODALITY THERAPY; GLIOMA; HUMANS; PALLIATIVE CARE; SALVAGE THERAPY;

EID: 0031935598     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Black PMcL. Brain tumors (Part 1). New Engl J Med 1991; 324:1471-1476
2. Black PMcL. Brain tumors (Part 2). New Engl J Med 1991; 324:1555-1564
3. Walker AE, Robins M, Weinfeld FD. Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology 1985; 35:219-226
4. Mahaley MS, Mettlin C, Natarajan N, Laws ER, Peace BB. National survey of patient care for brain-tumor patients. J Neurosurg 1989; 71:826-836
5. Riggs JE. Rising primary malignant brain tumor mortality in the elderly. Arch Neurology 1995; 52:571-575
6. Duffner PK, Horowitz ME, Krischer JP, Friedman HS, Burger PC, Cohen ME, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 1993; 328:1725-1731
7. Forsyth PA, Posner B. Headaches in patients with brain tumors: A study of 111 patients. Neurology 1993; 43:1678-1683
8. Grant R, Liang BC, Page MA, Crane DL, Greenberg HS, Junck L. Age influences chemotherapy response in astrocytomas. Neurology 1995; 45:929-933
9. Ciric I, Rovin R, Cozzens JW, Eller TW, Vick NA, Mikhael MA. Role of surgery in the treatment of malignant cerebral gliomas. In Malignant Cerebral Glioma. Park Ridge, III: American Association of Neurological Surgeons, 1990, pp 141-153
10. Kuratsu J-I, Ushio Y. Epidemiological study of primary intracranial tumors: A regional survey in Kumamoto Prefecture in the southern part of Japan. J Neurosurg 1996; 84:946-950
11. Ammirati M, Vick NA, Liao YL, Ciric I, Mikhael MA. Effect of the extent of surgery on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurology 1987; 21:201-206
12. Barker FG, Prados MD, Chang SM, Gutin PH, Lamborn KR, Larson DA, et al. Radiation response and survival time in patients with glioblastoma multiforme. J Neurosurg 1996; 84:442-448
13. Shapiro WR, Green SB, Burger PC, Mahaley MS, Selker RG, VanGilder JC, et al. Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. J Neurosurg 1989; 71:1-9
14. Halperin EC, Burger PC: Conventional external beam radiotherapy for central nervous system malignancies. In Frank BD (Ed): Symposium on Neuro-oncology, vol 3, Neurologic Clinics, 4th ed. York, Penn: WB Saunders, 1985, pp 867-882
15. Florell RC, MacDonald DR, Irish WD, Bernstein M, Leibel SA, Gutin PH, et al. Selection bias, survival, and brachytherapy for glioma. J Neurosurg 1992; 76:179-183
16. Levin VA: Chemotherapy of primary brain tumors. In Frank BD (Ed): Symposium on Neuro-oncology, vol 3, Neurologic Clinics, 4th ed. York, Penn: WB Saunders; 1985, pp 855-866
17. Kornblith PL, Walker M. Chemotherapy for malignant gliomas. J Neurosurg 1988; 68:1-17
18. Levin VA, Silver P, Hannigan J, Wara WM, Gutin PH, Davis RL, et al. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. J Rad One Biol Phys 1990; 18:321-324
19. Stewart DJ. The role of chemotherapy in the treatment of gliomas in adults. Cancer Treat Rev 1989; 16:129-160
20. Levin VA, Prados MD. Treatment of recurrent gliomas and metastatic brain tumors with a polydrug protocol designed to combat nitrosourea resistance. J Clin Oncol 1992; 10:766-771
21. Longee DC, Friedman HS, Albright RE, Burger PC, Oakes WJ, Moore JO, et al. Treatment of patients with recurrent gliomas with cyclophosphamide and vincristine. J Neurosurg 1990; 72:583-588
22. Mechtler L, Gleason MJ, Yung WKA. Phase II trial of intravenous carboplatin in patients with recurrent gliomas. Neurology 1989; 39(Suppl 1):311
23. Newton HB, Junck L, Bromberg J, Page MA, Greenberg HS. Procarbazine chemotherapy in the treatment of recurrent malignant astrocytomas after radiation and nitrosourea failure. Neurology 1990; 40:1743-1746
24. Spence AM, Berger MS, Livingston RB, Bleyer A. Phase II evaluation of high-dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chlorethylnitrosourea failure. J Neuroonc 1992; 12:187-191
25. Shapiro WR, Green SB, Burger PC, Selker RG, VanGlider JC, Robertson JT, et al. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma. J Neurosurgery 1987; 66:313-315
26. Fadul C, Wood J, Thaler H, Galicich J, Patterson RH, Posner JB. Morbidity and mortality of craniotomy for excision of supratentorial gliomas. Neurology 1988:38:1374-1379
27. MacDonald DR, Cascino TL, Schold C, Gregory C. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990; 8:1277-1280